Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-21-014543

Chief Commercial Officer sold 8,554 shares at $2.09 ($17,861)

From the SEC's structured data for this filing

Trades in this filing

Evanson Jeff · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-02-23 Sale : show line 1 in the form −8,554 $2.09 $17,861 1,141,930 D
Open-market sales · 8,554 sh · avg $2.09 · $17,861
Loading xslF345X03/doc4.xml…